These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 3035519)

  • 21. [The activity of the neurohumoral regulatory systems, the status of the electrolyte balance and the clinical efficacy of Renitec in hypertension patients].
    Ol'binskaia LI; Pinskaia EV; Bol'shakova TD; Anastas'ina GV; Tiabenkova VF
    Ter Arkh; 1996; 68(4):54-7. PubMed ID: 9324794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Concentrations of kininogen and prekallikrein in plasma and activity of plasma renin depending on the type of blood pressure response to captopril in patients with arterial hypertension].
    Zebrowska-Lupina I; Kolber-Postepska B; Markiewicz M; Horubała-Bielak G
    Wiad Lek; 1994 Apr; 47(7-8):241-7. PubMed ID: 7941572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the beta-receptor blocking agent visken on blood pressure of hypertensive patients, on plasma renin activity and electrolytes.
    Sonkodi S; Pap A; Varró V
    Ther Hung; 1976; 24(2):60-2. PubMed ID: 982340
    [No Abstract]   [Full Text] [Related]  

  • 25. Enalapril and enalapril-hydrochlorothiazide in the treatment of essential hypertension. The Enalapril-Hydrochlorothiazide in Essential Hypertension Canadian Working Group.
    Clin Ther; 1993; 15(2):364-73. PubMed ID: 8519044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Capillary blood cell velocity in finger nailfold: effect of enalapril and mibefradil in patients with mild to moderate hypertension.
    Martina B; Frach B; Surber C; Drewe J; Battegay E; Gasser P
    Microvasc Res; 1999 Mar; 57(2):94-9. PubMed ID: 10049657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension.
    Fagard R; Lijnen P; Pardaens K; Thijs L; Vinck W
    J Hum Hypertens; 2001 Mar; 15(3):161-7. PubMed ID: 11317199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The importance of studying the renin-angiotensin-aldosterone system in essential arterial hypertension in clinical practice. Activity of the renin-angiotensin-aldosterone system during treatment of hypertension with ACE-inhibitors and beta blockers].
    Hrnciar J; Hrnciarová M; Lepej J; Okálová D; Kreze A; Chamulová M
    Vnitr Lek; 1994 Sep; 40(9):557-62. PubMed ID: 7975357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.
    Biollaz J; Brunner HR; Gavras I; Waeber B; Gavras H
    J Cardiovasc Pharmacol; 1982; 4(6):966-72. PubMed ID: 6185790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effect of enalapril on serum aldosterone in essential hypertension.
    Sánchez RA; Ramírez AJ; Muscara M; Gilbert BH; Marcó E; Moledo LI
    Medicina (B Aires); 1987; 47(3):256-60. PubMed ID: 2831444
    [No Abstract]   [Full Text] [Related]  

  • 31. [Evaluation of the effectiveness of an angiotensin-converting enzyme inhibitor with various methods of continuous recording of blood pressure].
    Germanò G; Ciavarella M; Ferrucci A; Molle G; Corsi V
    Cardiologia; 1986 Feb; 31(2):149-54. PubMed ID: 3024834
    [No Abstract]   [Full Text] [Related]  

  • 32. [Arterial hypertension. A new classification and therapy based on renin plasma activity].
    Luna RL; Carrasco RM
    Arq Bras Cardiol; 1975 Jun; 28(3):277-91. PubMed ID: 1180712
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effects of enalapril on lowering blood pressure and protecting the myocardium in rats].
    Zhang J
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Apr; 18(2):84-6. PubMed ID: 2170093
    [No Abstract]   [Full Text] [Related]  

  • 34. [Evaluation and significance of the plasma renin activity in hypertension].
    Consolo F; Arrigo F; Russo A; Pitrone F; Virga T
    Boll Soc Ital Cardiol; 1976; 21(9):1641-50. PubMed ID: 1031321
    [No Abstract]   [Full Text] [Related]  

  • 35. Interaction between enalapril and propofol.
    Littler C; McConachie I; Healy TE
    Anaesth Intensive Care; 1989 Nov; 17(4):514-5. PubMed ID: 2556948
    [No Abstract]   [Full Text] [Related]  

  • 36. [Inhibition of acid-activation of inactive renin by heparin].
    Aoi W; Akahoshi M; Takahara A; Seto S; Hashiba K
    Nihon Jinzo Gakkai Shi; 1987 Aug; 29(8):1071-6. PubMed ID: 3320422
    [No Abstract]   [Full Text] [Related]  

  • 37. [Plasma renin and angiotensinase activity in primary arterial hypertension in children and adolescents].
    Lupal'tseva SE
    Pediatr Akus Ginekol; 1976; ():15-6. PubMed ID: 181723
    [No Abstract]   [Full Text] [Related]  

  • 38. Nonsteroidal anti-inflammatory drugs, and hypertension.
    Kisch ES; Fischel B; Yaron M
    Ann Intern Med; 1988 Aug; 109(4):344. PubMed ID: 3293496
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antireticular cytotoxic serum in the treatment of hypertension].
    Gandzha IM; Miagkaia IP
    Vrach Delo; 1977 Jan; (1):47-51. PubMed ID: 65837
    [No Abstract]   [Full Text] [Related]  

  • 40. [Enalapril in the treatment of primary hypertension: its effect on blood pressure and plasma renin activity].
    Sznajderman M; Cybulska I; Niegowska J; Strzałkowska M; Kabat M; Kupść W
    Pol Tyg Lek; 1986 Dec 22-29; 41(51-52):1607-11. PubMed ID: 3035519
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.